explore -WSS

explore

author：leisure time 2025-09-27 09:59:08 - browse：9

illustration of a colorful DNA strand, partly broken into pieces. -- health coverage from STAT — Adobe

BALTIMORE — An ambitious effort to cure HIV with CRISPR genome editing fell short in an early clinical trial, investigators announced Friday morning.

In the study, run by Excision BioTherapeutics, researchers tried to use the gene editing tool to address a chief reason HIV has been so hard to cure. While antiviral drugs can clear patients of replicating virus, HIV is able to worm its way into a patients’ own DNA in certain cells. If the patient ever stops taking medicines, those cells start pumping out HIV particles and the infection roars back.

Researchers hoped they could send CRISPR to those cells and, by cutting the HIV DNA lurking there at two spots, slice out the virus. In the Phase 1 trial, investigators administered the treatment to five patients. They then took three of them off conventional antiviral treatment.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Senators: Long

WSS

Intarcia’s device

Pentagon will tighten controls on classified information after Discord leak

Suspect in Ukraine detonates explosives at a courthouse, killing himself and wounding 2 officers

FDA panel to weigh approval of NurOwn, controversial ALS drug

Former New York Mayor de Blasio and wife announce separation, but not divorce

Experts study whether long Covid risk adds up with each reinfection

Wikipedia

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

entertainment

Cancer drug shortages should be causing more outrage

'Insanity': 4th of July mass shootings across US kill 13, injure more than 80

Activists slam private health insurers over coverage restrictions

What Congress can do to address the rural doctor shortage

The cancer drug shortage isn’t new — and neither are the solutions

Man with guns arrested near Obama home 'attempted to evade' Secret Service: Prosecutors

Hollywood unions extend contract negotiations for actors

Second xenotransplant done with gene

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

CommonSpirit Health keeps growing, even as it loses money

Wikipedia

Myanmar's Supreme Court hears arguments in 2 appeals by ousted leader Aung San Suu Kyi

How AI helped researchers track recovery from depression

Princess Kate attends Wimbledon with Roger Federer: See the photos

Pope Francis asks Church to identify 21st

Dramatic video released of Russian fighter jets 'harassing' US drones over Syria

1 in 4 Americans hadn't contracted COVID by the end of 2022, CDC estimates

leisure time

focus

hotspot

hotspot